RAB0980
Phosphotyrosine MET / Hepatocyte Growth Factor Receptor ELISA Kit
Faça loginpara ver os preços organizacionais e de contrato
Selecione um tamanho
1 KIT
R$ 3.289,00
R$ 3.289,00
Check Cart for Availability
Selecione um tamanho
Alterar visualização
1 KIT
R$ 3.289,00
About This Item
Código UNSPSC:
41116158
NACRES:
NA.32
R$ 3.289,00
Check Cart for Availability
reatividade de espécies
human
técnica(s)
ELISA: suitable
assay range
inter-assay cv: <10%
intra-assay cv: <12%
Condições de expedição
wet ice
temperatura de armazenamento
−20°C
Informações sobre genes
human ... MET(4233)
Categorias relacionadas
Descrição geral
The antibody pair provided in this kit recognizes Human Tyrosine-Phosphorylated-MET.
Aplicação
For research use only. Not for use in diagnostic procedures.
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
Componentes do kit também disponíveis separadamente
Nº do produto
Descrição
SDS
- RABHRP6Phosphotyrosine ELISA HRP-StreptavidinSDS
Palavra indicadora
Warning
Frases de perigo
Declarações de precaução
Classificações de perigo
Met. Corr. 1
Código de classe de armazenamento
8A - Combustible corrosive hazardous materials
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Escolha uma das versões mais recentes:
Certificados de análise (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.
Se precisar de ajuda, entre em contato Atendimento ao cliente
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Qian Wen et al.
Journal of translational medicine, 12, 114-114 (2014-06-03)
Autologous transplantation of modified mesenchymal stem cells (MSCs) is a promising candidate for the treatment of the refractory clinical disease, avascular necrosis of the femoral head (ANFH). Our previous attempts by compounding MSCs with medical fibrin glue to treat ANFH
Jesse Hudson et al.
Molecular and cellular biology, 34(19), 3689-3701 (2014-07-30)
Breast cancers are stratified into distinct subtypes, which influence therapeutic responsiveness and patient outcome. Patients with luminal breast cancers are often associated with a better prognosis relative to that with other subtypes. However, subsets of patients with luminal disease remain
Ji-Dong Chen et al.
Asian Pacific journal of cancer prevention : APJCP, 15(11), 4545-4548 (2014-06-28)
To investigate the changes of serum vascular endothelial growth factor (VEGF), soluble interleukin-2 receptor (SIL-2R) and hepatocyte growth factor (HGF) contents in patients with primary hepatocellular carcinoma (HCC) before and after percutaneous microwave coagulation therapy (PMCT) and determine their clinical
Mishaal B Patel et al.
Carcinogenesis, 35(8), 1891-1900 (2014-05-31)
Activated cancer-associated human pancreatic stellate cells (CAhPSCs, which produce the collagenous stroma of pancreatic cancer [PC]) are known to play a major role in PC progression. Apart from inducing cancer cell proliferation and migration, CAhPSCs have also been implicated in
F Vasuri et al.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 48(4), 430-437 (2014-06-21)
Hepatocyte growth factor (HGF), the c-Met receptor, and hypoxia-inducible factor (HIF) are crucial for regenerative processes including ischemic wound healing. The aims of the present study are (a) to analyze the tissue c-Met and HIF-1α expression in skin from patients
Active Filters
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica
